Lindbrook Capital’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $5.09K | Buy |
298
+177
| +146% | +$3.03K | ﹤0.01% | 1945 |
|
|
2024
Q4 | $3K | Sell |
121
-7
| -5% | -$173 | ﹤0.01% | 2177 |
|
|
2024
Q3 | $3.65K | Hold |
128
| – | – | ﹤0.01% | 2139 |
|
|
2024
Q2 | $3.38K | Buy |
128
+73
| +133% | +$1.93K | ﹤0.01% | 2168 |
|
|
2024
Q1 | $1.78K | Sell |
55
-164
| -75% | -$5.3K | ﹤0.01% | 2284 |
|
|
2023
Q4 | $9.23K | Buy |
219
+164
| +298% | +$6.91K | ﹤0.01% | 1594 |
|
|
2023
Q3 | $2.11K | Buy |
55
+34
| +162% | +$1.31K | ﹤0.01% | 2109 |
|
|
2023
Q2 | $398 | Hold |
21
| – | – | ﹤0.01% | 2553 |
|
|
2023
Q1 | $326 | Sell |
21
-57
| -73% | -$885 | ﹤0.01% | 2669 |
|
|
2022
Q4 | $1.39K | Sell |
78
-21
| -21% | -$373 | ﹤0.01% | 2382 |
|
|
2022
Q3 | $1K | Buy |
99
+42
| +74% | +$424 | ﹤0.01% | 2358 |
|
|
2022
Q2 | $0 | Sell |
57
-232
| -80% | – | ﹤0.01% | 2624 |
|
|
2022
Q1 | $2K | Buy |
+289
| New | +$2K | ﹤0.01% | 2013 |
|
|
2020
Q3 | – | Sell |
-500
| Closed | -$12K | – | 1791 |
|
|
2020
Q2 | $12K | Sell |
500
-500
| -50% | -$12K | ﹤0.01% | 777 |
|
|
2020
Q1 | $16K | Buy |
+1,000
| New | +$16K | 0.01% | 615 |
|